Related Experiment Video
Updated: Jan 9, 2026
08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
10.3K
The FAK-NRF2 Axis Alleviates DOX-Induced Cardiotoxicity by Inhibiting Ferroptosis.
Ying Zhao1,2, Mo Chen1, Linghui Kong1
1Department of Anesthesiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
Summary
Focal adhesion kinase (FAK) protects against doxorubicin (DOX) cardiotoxicity by inhibiting ferroptosis. Enhancing the FAK/NRF2 pathway may preserve heart function in patients undergoing chemotherapy.
Area of Science:
- Cardiology
- Molecular Biology
- Oncology
Background:
- Doxorubicin (DOX) chemotherapy causes significant cardiotoxicity.
- The molecular mechanisms underlying DOX-induced cardiotoxicity are not fully understood.
- Focal adhesion kinase (FAK) is vital for cardiac survival signaling.
Purpose of the Study:
- To investigate the role of FAK in DOX-induced cardiotoxicity.
- To elucidate the molecular mechanisms by which FAK influences DOX cardiotoxicity.
- To explore potential therapeutic strategies targeting the FAK pathway.
Main Methods:
- Overexpression of FAK in SKOV3 mice and AC16 cardiomyocytes.
- Assessment of DOX-induced cardiotoxicity and ferroptosis.
- Analysis of the FAK/NRF2/HDAC5 signaling axis.
- NRF2 knockdown experiments.
Main Results:
- FAK overexpression ameliorated DOX-induced cardiomyopathy by inhibiting ferroptosis.
- DOX treatment suppressed FAK activity, leading to ferroptosis in cardiomyocytes.
- FAK overexpression upregulated Nuclear factor erythroid 2-related factor 2 (NRF2), conferring protection.
- NRF2 knockdown abolished the protective effects of FAK.
- Histone deacetylase 5 (HDAC5) was implicated in the protective pathway.
Conclusions:
- FAK is a critical regulator of DOX-induced cardiotoxicity.
- FAK protects cardiac cells from DOX-induced ferroptosis, partly via NRF2.
- Enhancing the FAK/NRF2/HDAC5 signaling axis is a potential therapeutic strategy for DOX cardiotoxicity.
Related Concept Videos
01:16Necrosis
6.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888
01:46Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K